Zobrazeno 1 - 10
of 576
pro vyhledávání: '"Christian Recher"'
Autor:
Emilie Bérard, Christoph Röllig, Sarah Bertoli, Arnaud Pigneux, Suzanne Tavitian, Michael Kramer, Hubert Serve, Martin Bornhäuser, Uwe Platzbecker, Carsten Müller-Tidow, Claudia D. Baldus, David Martínez-Cuadrón, Josefina Serrano, Pilar Martínez-Sánchez, Eduardo Rodríguez Arbolí, Cristina Gil, Juan Bergua, Teresa Bernal, Adolfo de la Fuente Burguera, Eric Delabesse, Audrey Bidet, Pierre-Yves Dumas, Pau Montesinos, Christian Récher
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 7, Pp 1-8 (2022)
Abstract In a context of therapeutic revolution in older adults with AML, it is becoming increasingly important to select patients for the various treatment options by taking account of short-term efficacy and toxicity as well as long-term survival.
Externí odkaz:
https://doaj.org/article/a79de68b14424fe89380e50d0b454990
Autor:
Sophie Le Grand, Alban Canali, Sarah Bertoli, Christian Recher, Véronique De Mas, Jean‐Baptiste Rieu
Publikováno v:
eJHaem, Vol 5, Iss 3, Pp 635-637 (2024)
Externí odkaz:
https://doaj.org/article/ca503288d34c47f09e593710fd866bb3
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
CPX-351, a dual-drug liposomal encapsulation of daunorubicin and cytarabine in a 1:5 molar ratio, is approved for the treatment of newly diagnosed therapy-related acute myeloid leukemia (AML) or AML with myelodysplasia-related changes. In a pivotal p
Externí odkaz:
https://doaj.org/article/1cda4855cb34403eb6a598e66a41608c
Autor:
Sylvain Garciaz, Pierre Bories, Leonor Lopez Almeida, Jean-Marie Boher, Coralie Belanger, Christian Recher, Olivier Hermine, Norbert Vey, Pierre Launay
Publikováno v:
HemaSphere, Vol 7, p e45170e9 (2023)
Externí odkaz:
https://doaj.org/article/877f29cdffd34c1f968a8c97ba21034e
Autor:
Hartmut Döhner, Pau Montesinos, Susana Vives Polo, Ewa Zarzycka, Jianxiang Wang, Marta Riva, Michael Heuser, Rodrigo Calado, Andre Schuh, Su-Peng Yeh, Jianan Hui, Diego Gianolio, Prapti A Patel, Christian Recher, Stephane de Botton
Publikováno v:
HemaSphere, Vol 7, p e83152da (2023)
Externí odkaz:
https://doaj.org/article/de84a0d76ef942b08f1b1492c7aa6d27
Autor:
Achraf Bennis, Philippe Leleux, Alban Canali, Caroline De Pourtales, Sandrine Mouysset, David Simoncini, Pierre Brousset, Francois-Xavier Frenois, Christian Recher, Jean-Marc Alliot, Jean-Baptiste Rieu, Sarah Bertoli
Publikováno v:
HemaSphere, Vol 7, p e5127496 (2023)
Externí odkaz:
https://doaj.org/article/355a9f03dba942319d09ef5a3fc65ee1
Autor:
Montserrat Arnan, Pau Montesinos, Stéphane de Botton, Christian Recher, Lydia Wunderle, Michael Emig, Andreas Harstrick, Kerstin Pietzko, Sheena Pinto, Paulien Ravenstijn, Naval Daver
Publikováno v:
HemaSphere, Vol 7, p e2404792 (2023)
Externí odkaz:
https://doaj.org/article/b4d7a74d16094c5d9e7ece66f935eeac
Autor:
Guillaume Beziat, Suzanne Tavitian, Francois-Xavier Arnaud, Françoise Izar, Justine Attal, Cécile Borel, Christian Recher, Anne Ducassou
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 14, Iss 6, Pp 601-604 (2022)
Acute myeloid leukemia (AML) may extend to extra-medullary sites at diagnosis or at relapse, either isolated or associated with bone marrow disease. Granulocytic sarcoma of uterine cervix is rare, and there is no established treatment for this diseas
Externí odkaz:
https://doaj.org/article/a5330ccd3e294c3ebc6ab5deac3846b9
Autor:
Ruben Mesa, Srdan Verstovsek, Uwe Platzbecker, Vikas Gupta, David Lavie, Pilar Giraldo, Christian Recher, Jean-Jacques Kiladjian, Stephen T. Oh, Aaron T. Gerds, Timothy Devos, Francesco Passamonti, Alessandro M. Vannucchi, Miklos Egyed, Ewa Lech-Maranda, Andrzej Pluta, Lars Nilsson, Kazuya Shimoda, Donal McLornan, Jun Kawashima, Barbara Klencke, Mei Huang, Bryan Strouse, Claire Harrison
Publikováno v:
Haematologica, Vol 109, Iss 2 (2023)
Externí odkaz:
https://doaj.org/article/1cead2f39051428b8b89ac763d0e25b1
Autor:
Alexander E. Perl, Naoko Hosono, Pau Montesinos, Nikolai Podoltsev, Giovanni Martinelli, Nicki Panoskaltsis, Christian Recher, Catherine C. Smith, Mark J. Levis, Stephen Strickland, Christoph Röllig, Marco Groß-Langenhoff, Wen-Chien Chou, Je-Hwan Lee, Hisayuki Yokoyama, Nahla Hasabou, Qiaoyang Lu, Ramon V. Tiu, Jessica K. Altman
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 5, Pp 1-9 (2022)
Abstract The fms-like tyrosine kinase 3 (FLT3) inhibitor gilteritinib is indicated for relapsed or refractory (R/R) FLT3-mutated acute myeloid leukemia (AML), based on its observed superior response and survival outcomes compared with salvage chemoth
Externí odkaz:
https://doaj.org/article/177517e470014866a24e2133dc705fd7